Insider Trades Superinvestors Grand Portfolio

DH

DataHeimdall

Financial transparency data from public SEC filings.

Product

Insider Trades
Grand Portfolio

Company

About
Blog
Contact

Legal

Privacy Policy
Terms of Service
Disclaimer

© 2026 DataHeimdall. All rights reserved.Data sourced from SEC EDGAR public filings.

Clare Kahn – Insider Trading Activity | DataHeimdall

Clare Kahn

Director at Stoke Therapeutics, Inc.

CIK: 1849236

1

Total trades

1

Buys

0

Sells

Apr 3, 2026

Last trade

Date	Stock	Type	Shares	Value	Src
Apr 3, 2026	STOKStoke Therapeutics, Inc.	Buy	30,782	–